Moderate

Zollinger‑Ellison Syndrome – Acid Hypersecretion - Causes, Treatment & When to See a Doctor

📅 Updated: June 2026 ⏱️ 6 min read ✅ Medically reviewed

Contents

```html Zollinger‑Ellison Syndrome – Acid Hypersecretion

Zollinger‑Ellison Syndrome – Acid Hypersecretion

What is Zollinger‑Ellison Syndrome – Acid Hypersecretion?

Zollinger‑Ellison syndrome (ZES) is a rare disorder in which one or more tumors, called gastrin‑producing neuroendocrine tumors (gastrinomas), develop in the pancreas or duodenum. These tumors secrete large amounts of the hormone gastrin, which in turn stimulates the stomach lining to produce excessive gastric acid. The resulting acid hypersecretion can damage the lining of the stomach and duodenum, leading to severe peptic ulcers, diarrhea, and malabsorption.

Although ZES accounts for less than 1 % of all peptic‑ulcer disease, it is clinically important because the ulcers are often multiple, refractory to standard therapy, and can be located in unusual places such as the jejunum. Early recognition and treatment are crucial to prevent complications such as perforation, bleeding, and, in rare cases, gastric cancer.

Common Causes

Acid hypersecretion in ZES is caused by the uncontrolled release of gastrin from gastrinomas. While the primary cause is the tumor itself, several other conditions can produce similar hyperacidic states. Understanding these helps clinicians differentiate ZES from more common disorders.

  • Gastrinomas (Zollinger‑Ellison syndrome) – the defining cause.
    • <
  • Multiple Endocrine Neoplasia type 1 (MEN‑1) – up to 25 % of ZES patients have MEN‑1, a hereditary syndrome that also causes tumors of the parathyroid and pituitary glands.
  • Familial Gastrinoma Syndrome – rare autosomal‑dominant inheritance of gastrinomas without other MEN‑1 features.
  • Chronic Helicobacter pylori infection – can increase gastrin release and cause ulcer disease, though usually not to the level seen in ZES.
  • Proton‑pump inhibitor (PPI) rebound hypergastrinemia – long‑term high‑dose PPI use may raise gastrin levels but rarely causes the massive acid output seen in ZES.
  • Chronic renal failure – reduced clearance of gastrin can contribute to mildly elevated gastrin levels.
  • Coronary artery bypass graft (CABG) surgery – postoperative hypergastrinemia is documented but usually transient.
  • Idiopathic hypergastrinemia – elevated gastrin without an identifiable tumor; must be ruled out after thorough imaging.
  • Somatostatin‑secreting tumor (somatostatinoma) treatment – paradoxically, withdrawal can cause a rebound rise in gastrin.
  • Autoimmune gastritis (type A) – leads to hypo‑acidic state, but in rare cases co‑exists with gastrin‑secreting lesions.

Associated Symptoms

Because excess acid attacks the gastrointestinal lining, patients with ZES often present with a combination of the following:

  • Recurrent or persistent peptic ulcers (often > 3 cm, multiple, or located beyond the duodenum).
  • Severe, watery diarrhea (up to 5–10 stools/day) caused by acid inactivation of pancreatic enzymes.
  • Unexplained weight loss due to malabsorption and reduced appetite.
  • Abdominal pain or cramping, especially after meals.
  • Heartburn and gastro‑esophageal reflux disease (GERD) symptoms.
  • Nausea or vomiting, occasionally with blood if ulcer erodes a vessel.
  • Fatigue and anemia from chronic blood loss.
  • Occasional gastrointestinal bleeding** (melena or hematochezia).

When to See a Doctor

Any of the following signs should prompt prompt medical evaluation:

  • Recurrent ulcers that do not heal after 8‑12 weeks of standard therapy.
  • Ulcers that appear beyond the duodenum (e.g., jejunum, ileum).
  • Severe, unexplained diarrhea lasting more than a week.
  • Unintentional weight loss > 5 % of body weight within a month.
  • Persistent nausea, vomiting, or abdominal pain despite over‑the‑counter medications.
  • Blood in the stool or vomit (melena, hematemesis).
  • Family history of MEN‑1 or other endocrine tumors.

Early consultation can shorten the time to diagnosis, allowing for less invasive treatment and reducing the risk of complications.

Diagnosis

Diagnosing ZES involves a stepwise approach that combines clinical suspicion with laboratory and imaging studies.

1. Laboratory Tests

  • Fasting serum gastrin level – a level > 1,000 pg/mL (≥ 5‑times the upper limit of normal) in the presence of acid hypersecretion is highly suggestive.
  • Secretin stimulation test – paradoxical rise in gastrin after IV secretin; a > 120 pg/mL increase confirms gastrinoma in many centers.
  • Basic metabolic panel to assess for hypokalemia, metabolic alkalosis (from chronic vomiting/diarrhea), and renal function.
  • Complete blood count for anemia.

2. Endoscopic Evaluation

  • Upper endoscopy (EGD) – visualizes ulcers, takes biopsies to rule out malignancy, and can detect mucosal changes.
  • Capsule endoscopy or double‑balloon enteroscopy – useful for locating ulcers beyond the reach of standard EGD.

3. Imaging to Locate Tumors

  • Contrast‑enhanced CT scan of the abdomen and pelvis – first‑line for tumor localization.
  • Magnetic resonance imaging (MRI) – especially for liver metastases.
  • Somatostatin receptor scintigraphy (Octreoscan) or Ga‑68 DOTATATE PET/CT – highly sensitive for detecting small gastrinomas and metastatic disease.
  • EUS (Endoscopic ultrasound) – excellent for identifying pancreatic lesions <2 cm.

4. Genetic Testing (when appropriate)

If there is a personal or family history suggestive of MEN‑1, testing for mutations in the MEN1 gene is recommended.

Treatment Options

Therapy aims to (1) control acid production, (2) remove or reduce the tumor burden, and (3) manage complications.

Medical Management

  • Proton‑pump inhibitors (PPIs) – high‑dose omeprazole, esomeprazole, or lansoprazole are the mainstay; they can suppress acid output > 90 % and heal ulcers.
  • H2‑receptor antagonists – used adjunctively if PPIs are insufficient.
  • Octreotide or lanreotide (somatostatin analogues) – inhibit gastrin release; useful when tumors are unresectable or metastatic.
  • Antidiarrheal agents – loperamide or diphenoxylate‑atropine for symptom control.
  • Calcium and vitamin D supplementation – if malabsorption leads to deficiencies.

Surgical Treatment

  • Enucleation – removal of a solitary, well‑localized gastrinoma (< 2 cm) while preserving pancreatic tissue.
  • Pancreaticoduodenectomy (Whipple procedure) – indicated for larger or multiple pancreatic tumors.
  • Distal pancreatectomy – for tumors located in the body or tail of the pancreas.
  • Debulking surgery – when complete resection isn’t feasible; reduces tumor load and may improve symptom control.

Targeted & Systemic Therapy

  • Everolimus or sunitinib – approved for advanced pancreatic neuroendocrine tumors; can slow progression.
  • Peptide receptor radionuclide therapy (PRRT) – uses radiolabeled somatostatin analogues for metastatic disease.
  • Chemotherapy – reserved for high‑grade neuroendocrine carcinomas; regimens often include streptozocin, 5‑FU, or temozolomide.

Home & Lifestyle Strategies

  • Take PPIs exactly as prescribed; do not skip doses.
  • Maintain a food diary to identify meals that aggravate diarrhea.
  • Stay hydrated; oral rehydration solutions can replace lost electrolytes.
  • Avoid alcohol, tobacco, and NSAIDs – they increase ulcer risk.
  • Small, frequent meals may reduce acid spikes.

Prevention Tips

Because ZES originates from a tumor, true primary prevention is limited. However, the following measures can reduce the risk of complications and support overall gastrointestinal health:

  • Adhere to regular surveillance if you have MEN‑1 or a known gastrinoma.
  • Limit long‑term, high‑dose use of PPIs unless medically indicated; discuss tapering plans with your physician.
  • Eradicate Helicobacter pylori infection promptly—while it does not cause ZES, it can exacerbate ulcer disease.
  • Follow a balanced diet rich in fiber, lean protein, and low in highly acidic foods (citrus, coffee) if you have acid‑related symptoms.
  • Maintain healthy body weight; obesity is linked to increased risk of many endocrine tumors.
  • Avoid smoking and excessive alcohol consumption, both of which worsen ulcer healing.

Emergency Warning Signs

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe abdominal pain that does not improve with medication.
  • Vomiting blood (bright red or “coffee‑ground” material).
  • Black, tarry stools (melena) indicating possible gastrointestinal bleeding.
  • Signs of shock: rapid heartbeat, low blood pressure, pale or clammy skin, dizziness or fainting.
  • Severe, persistent diarrhea leading to dehydration (dry mouth, dizziness, reduced urine output).
  • High fever (> 101 °F / 38.3 °C) accompanied by abdominal pain, which may suggest perforation or infection.

Key Takeaways

  • Zollinger‑Ellison syndrome is a rare, gastrin‑producing tumor that causes dangerous acid hypersecretion.
  • Typical presentation includes refractory peptic ulcers, watery diarrhea, and weight loss.
  • Diagnosis requires a combination of very high fasting gastrin levels, secretin stimulation testing, endoscopy, and imaging.
  • High‑dose PPIs control acid; surgery or targeted therapies address the tumor.
  • Prompt medical attention for ulcer complications or abrupt worsening of symptoms can be lifesaving.

For the most up‑to‑date information and personalized advice, consult a gastroenterologist or an endocrinology specialist familiar with neuroendocrine tumors.

Sources: Mayo Clinic, National Institutes of Health (NIH) – National Institute of Diabetes and Digestive and Kidney Diseases, Cleveland Clinic, American Cancer Society, World Health Organization (WHO), peer‑reviewed journals (e.g., Journal of Clinical Endocrinology & Metabolism, Annals of Surgery).

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References